Topic: Innovation

Accurate analytical characterization is essential throughout oligonucleotide development, supporting impurity profiling, stability assessment, and ultimately the delivery of…

As the leading peptide manufacturer, Bachem is at the forefront of innovative synthesis methods. One cutting-edge approach is…

    Disulfide bond formation is a key step in the manufacture of cysteine‑containing peptides, yet established oxidation…

  The rising demands for therapeutic oligonucleotides requires scalable, efficient, and more sustainable manufacturing solutions. Stirred bed technology…

As the demand for peptide-based therapeutics continues to grow, the need for innovative, cost-efficient, and environmentally friendly manufacturing…

  Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising alternative,…

Oligonucleotide-based therapeutics are transforming modern medicine, offering targeted solutions for genetic disorders, cancer, cardiovascular disease, and CNS conditions.…

  Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising…

Peptides have the potential to expand the space of “druggable” targets. No wonder the number of them being under…